Additional file 1 of A novel minimally invasive OFM technique with orthotopic transplantation of hUC-MSCs and in vivo monitoring of liver metabolic microenvironment in liver fibrosis treatment

Additional file 1. Supplementary Figure 1. The characteritics of hUC-MSCs. A Morphology of hUC-MSCs at passage 4. B Surface markers of the isolated and cultured hUC-MSCs were detected using flow cytometry. More than 95% hUC-MSCs expressed CD73, CD90, CD105, and CD29, but not CD34, CD45, CD117, and HLA-DR. C Fluorescence image of CM-Dil-labeled hUC-MSCs. Supplementary Figure 2. PCA analysis of livers obtained from control and OFM groups based on metabolomic analysis.